Page last updated: 2024-11-05

trientine and Triple Negative Breast Neoplasms

trientine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Vitaliti, A3
Roccatani, I3
Iorio, E3
Perta, N3
Gismondi, A3
Chirico, M3
Pisanu, ME3
Di Marino, D3
Canini, A3
De Luca, A3
Rossi, L3

Other Studies

1 other study available for trientine and Triple Negative Breast Neoplasms

ArticleYear
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
    Cellular oncology (Dordrecht), 2023, Volume: 46, Issue:1

    Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe

2023
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
    Cellular oncology (Dordrecht), 2023, Volume: 46, Issue:1

    Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe

2023
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
    Cellular oncology (Dordrecht), 2023, Volume: 46, Issue:1

    Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe

2023
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
    Cellular oncology (Dordrecht), 2023, Volume: 46, Issue:1

    Topics: Amino Acid Oxidoreductases; Biological Availability; Cell Line, Tumor; Cell Movement; Copper; Epithe

2023